Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...
Capital Market on MSN
NSE SME Invicta Diagnostic starts with a healthy lift
The stock listed at Rs 100, a 17.65% premium to the IPO price, and is currently frozen at its lower limit of 5% over the ...
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.
You know, healthcare is changing so fast, and a lot of that has to do with computers getting smarter. We’re talking about ...
Comprehensive repository offering official resources, detailed guides, and reference materials for Device Doctor on Windows PCs. Designed to support users with reliable information and tools for ...
The Supreme Court yesterday disposed of a 2019 case challenging the age restriction of 35 years in Section 4(3)(i) of the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex ...
Comprehensive repository offering official resources, detailed guides, and reference materials for AIDA64 Extreme on Windows PCs. Designed to support users with accurate information and tools for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback